Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease
Release Date:
Interview with John Sims, author of Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease: The AMARANTH and DAYBREAK-ALZ Randomized Clinical Trials
Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease